Literature DB >> 868873

Maple syrup urine disease: branched-chain keto acid decarboxylation in fibroblasts as measured with amino acids and keto acids.

J Dancis, J Hutzler, R P Cox.   

Abstract

Branched-chain keto acid decarboxylase activity in skin fibroblasts from control subjects and from patients with classical and variant forms of maple syrup urine disease (MSUD) was measured with leucine and alpha-ketoisocaproic acid. When the keto acid was used as substrate in high concentrations (more than 5 mM), the three groups overlapped extensively, even classical cases of MSUD exhibiting decarboxylase activity. With leucine as substrate, decarboxylase activity plateaued at about 1.5 mM, and the three groups could be clearly differentiated. Classical cases of MSUD had minimal or no decarboxylase activity.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 868873      PMCID: PMC1685304     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  10 in total

1.  Subcellular distribution and cofactor function of human branched chain alpha-ketoacid dehydrogenase in normal and mutant cultured skin fibroblasts.

Authors:  D J Danner; L J Elsas
Journal:  Biochem Med       Date:  1975-05

2.  DETECTION OF THE HETEROZYGOTE IN MAPLE SYRUP URINE DISEASE.

Authors:  J DANCIS; J HUTZLER; M LEVITZ
Journal:  J Pediatr       Date:  1965-03       Impact factor: 4.406

3.  Metabolism of the white blood cells in maple-syrup-urine disease.

Authors:  J DANCIS; J HUTZLER; M LEVITZ
Journal:  Biochim Biophys Acta       Date:  1960-09-23

4.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

5.  Hypoxanthine phosphoribosyltransferase activity in intact fibroblasts from patients with X-linked hyperuricemia.

Authors:  M J Holland; A M DiLorenzo; J Dancis; M E Balis; T F Yü; R P Cox
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

6.  Rapid diagnosis of maple syrup urine disease (branched chain ketoaciduria) by micro-enzyme assay in leukocytes and fibroblasts.

Authors:  U Wendel; W Wöhler; H W Goedde; U Langenbeck; E Passarge; H W Rüdiger
Journal:  Clin Chim Acta       Date:  1973-05-30       Impact factor: 3.786

7.  Enzyme activity in classical and variant forms of maple syrup urine disease.

Authors:  J Dancis; J Hutzler; S E Snyderman; R P Cox
Journal:  J Pediatr       Date:  1972-08       Impact factor: 4.406

8.  The enzyme defect in maple syrup urine disease (branched chain ketoaciduria).

Authors:  J E Seegmiller; R G Westall
Journal:  J Ment Defic Res       Date:  1967-12

9.  Maple syrup urine disease: analysis of branched chain ketoacid decarboxylation in cultured fibroblasts.

Authors:  U Wendel; H Wentrup; H W Rüdiger
Journal:  Pediatr Res       Date:  1975-09       Impact factor: 3.756

10.  Variant maple syrup urine disease in mother and daughter.

Authors:  L A Zaleski; J Dancis; R P Cox; J Hutzler; W A Zaleski; A Hill
Journal:  Can Med Assoc J       Date:  1973-08-18       Impact factor: 8.262

  10 in total
  8 in total

1.  An asymptomatic variant of maple syrup urine disease without organic aciduria.

Authors:  M L Cabello; A M Garcia; J Dalmau; C Dominguez; C Conde
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

2.  Thiamin-responsive maple-syrup-urine disease: decreased affinity of the mutant branched-chain alpha-keto acid dehydrogenase for alpha-ketoisovalerate and thiamin pyrophosphate.

Authors:  D T Chuang; L S Ku; R P Cox
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

3.  Detection of heterozygotes in maple-syrup-urine disease: measurements of branched-chain alpha-ketoacid dehydrogenase and its components in cell cultures.

Authors:  D T Chuang; L S Ku; D S Kerr; R P Cox
Journal:  Am J Hum Genet       Date:  1982-05       Impact factor: 11.025

4.  Altered phosphorylation state of branched-chain 2-oxo acid dehydrogenase in a branched-chain acyltransferase deficient human fibroblast cell line.

Authors:  R S Eisenstein; G Hoganson; R H Miller; A E Harper
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

5.  Maple syrup urine disease: two different forms within a single family.

Authors:  J Frézal; O Amédée-Manesme; G Mitchell; S Heuertz; F Rey; J Rey; J M Saudubray
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

6.  Activities of branched-chain 2-oxo acid dehydrogenase and its components in skin fibroblasts from normal and classical-maple-syrup-urine-disease subjects.

Authors:  D T Chuang; W L Niu; R P Cox
Journal:  Biochem J       Date:  1981-10-15       Impact factor: 3.857

7.  Evaluation of plasma biomarkers of inflammation in patients with maple syrup urine disease.

Authors:  Giselli Scaini; Tássia Tonon; Carolina F Moura de Souza; Patricia F Schuck; Gustavo C Ferreira; João Quevedo; João Seda Neto; Tatiana Amorim; Jose S Camelo; Ana Vitoria Barban Margutti; Rafael Hencke Tresbach; Fernanda Sperb-Ludwig; Raquel Boy; Paula F V de Medeiros; Ida Vanessa D Schwartz; Emilio Luiz Streck
Journal:  J Inherit Metab Dis       Date:  2018-05-08       Impact factor: 4.982

8.  Metformin inhibits Branched Chain Amino Acid (BCAA) derived ketoacidosis and promotes metabolic homeostasis in MSUD.

Authors:  Davis S Sonnet; Monique N O'Leary; Mark A Gutierrez; Steven M Nguyen; Samiha Mateen; Yuehmei Hsu; Kylie P Mitchell; Antonio J Lopez; Jerry Vockley; Brian K Kennedy; Arvind Ramanathan
Journal:  Sci Rep       Date:  2016-07-04       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.